A. Kvarnström
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. Kvarnström has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
H. Quiding
2 shared publications- Rolf Karlsten
Department of Surgical Sciences/Anaesthesiology & Intensive Care, Uppsala University, Uppsala, Sweden
2 shared publications - Torsten Gordh
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
2 shared publications B.‐M. Emanuelsson
Astra Zeneca R&D, Södertälje, Sweden
1 shared publication
Latest Publications
- 11 February 2004
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 48 (4) , 498-506
The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury
Background: Pain following spinal cord injury (SCI) is a therapeutic challenge. Only a few treatments have been assessed in randomized, controlled trials. The primary objective of the present study was to examine the analgesic effect of ketamine and lidocaine in a group of patients with neuropathic pain below the level of spinal cord injury. We also wanted to assess sensory abnormalities to see if this could help us to identify responders and if treatments resulted in changes of sensibility.Methods: Ten patients with spinal cord injury and neuropathic pain below the level of injury were included. The analgesic effect of ketamine 0.4 mg kg−1 and lidocaine 2.5 mg kg−1 was investigated. Saline was used as placebo. The drugs were infused over 40 min. A randomized, double‐blind, three‐period, three‐treatment, cross‐over design was used. Systemic plasma concentrations of ketamine and lidocaine were assessed. Pain rating was performed using a visual analogue scale (VAS). Sensory function was assessed with a combination of traditional sensory tests and quantitative measurement of temperature thresholds.Results: Response to treatment, defined as 50% reduction in VAS‐score during infusion, was recorded in 5/10 in the ketamine, 1/10 in the lidocaine and 0/10 in the placebo groups. Neither ketamine nor lidocaine changed temperature thresholds or assessments of mechanical; dynamic and static sensibility. Nor could these sensory assessments predict response to treatment in this setting. Lidocaine and particularly ketamine were associated with frequent side‐effects.Conclusion: Ketamine but not lidocaine showed a significant analgesic effect in patients with neuropathic pain after spinal cord injury. The pain relief was not associated with altered temperature thresholds or other changes of sensory function.
- 11 February 2004
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 48 (4) , 498-506
The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury
Background: Pain following spinal cord injury (SCI) is a therapeutic challenge. Only a few treatments have been assessed in randomized, controlled trials. The primary objective of the present study was to examine the analgesic effect of ketamine and lidocaine in a group of patients with neuropathic pain below the level of spinal cord injury. We also wanted to assess sensory abnormalities to see if this could help us to identify responders and if treatments resulted in changes of sensibility.Methods: Ten patients with spinal cord injury and neuropathic pain below the level of injury were included. The analgesic effect of ketamine 0.4 mg kg−1 and lidocaine 2.5 mg kg−1 was investigated. Saline was used as placebo. The drugs were infused over 40 min. A randomized, double‐blind, three‐period, three‐treatment, cross‐over design was used. Systemic plasma concentrations of ketamine and lidocaine were assessed. Pain rating was performed using a visual analogue scale (VAS). Sensory function was assessed with a combination of traditional sensory tests and quantitative measurement of temperature thresholds.Results: Response to treatment, defined as 50% reduction in VAS‐score during infusion, was recorded in 5/10 in the ketamine, 1/10 in the lidocaine and 0/10 in the placebo groups. Neither ketamine nor lidocaine changed temperature thresholds or assessments of mechanical; dynamic and static sensibility. Nor could these sensory assessments predict response to treatment in this setting. Lidocaine and particularly ketamine were associated with frequent side‐effects.Conclusion: Ketamine but not lidocaine showed a significant analgesic effect in patients with neuropathic pain after spinal cord injury. The pain relief was not associated with altered temperature thresholds or other changes of sensory function.
- 10 July 2003
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 47 (7) , 868-877
The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain
Background: Neuropathic pain is often severe and resistant to pharmacological treatment. The aims of the present study were to assess the analgesic effect of ketamine and lidocaine and to investigate if measurement of different variables of sensibility could be used to identify responders. We also wanted to study if treatment resulted in changes of sensibility.Methods: Twelve patients with long‐lasting peripheral neuropathic pain of traumatic origin were included. The effects of ketamine hydrochloride (Ketalar®, Parke Davis) 0.4 mg/kg and lidocaine hydrochloride (Xylocain®, Astra) 2.5 mg/kg were investigated. Saline was used as placebo. The intensity of continuous pain was measured by a visual analogue scale (VAS). Warm and cold perception as well as heat and cold pain thresholds were assessed. Sensibility to touch was also tested. Systemic plasma concentrations of lidocaine and ketamine were assessed.Results: The mean reduction in VAS‐scores was 55%, 34% and 22% for ketamine, lidocaine and placebo, respectively. A significant difference was registered between ketamine and placebo (P = 0.009). Response to treatment (50% reduction in VAS‐score during infusion) was recorded in 7/12 in the ketamine, 4/12 in the lidocaine and 2/12 in the placebo group. Quantitative sensory testing (QST) of thermal sensitivity and sensory tests for mechanical stimuli could not separate responders from non‐responders and neither were the results from these assessments changed by the infusion of the drugs. Lidocaine and particularly ketamine were associated with frequent side‐effects, the most common being somnolence and dizziness.Conclusion: Ketamine showed a significant analgesic effect. The clinical usefulness is, however, limited by disturbing side‐effects.
- 10 July 2003
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 47 (7) , 868-877
The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain
Background: Neuropathic pain is often severe and resistant to pharmacological treatment. The aims of the present study were to assess the analgesic effect of ketamine and lidocaine and to investigate if measurement of different variables of sensibility could be used to identify responders. We also wanted to study if treatment resulted in changes of sensibility.Methods: Twelve patients with long‐lasting peripheral neuropathic pain of traumatic origin were included. The effects of ketamine hydrochloride (Ketalar®, Parke Davis) 0.4 mg/kg and lidocaine hydrochloride (Xylocain®, Astra) 2.5 mg/kg were investigated. Saline was used as placebo. The intensity of continuous pain was measured by a visual analogue scale (VAS). Warm and cold perception as well as heat and cold pain thresholds were assessed. Sensibility to touch was also tested. Systemic plasma concentrations of lidocaine and ketamine were assessed.Results: The mean reduction in VAS‐scores was 55%, 34% and 22% for ketamine, lidocaine and placebo, respectively. A significant difference was registered between ketamine and placebo (P = 0.009). Response to treatment (50% reduction in VAS‐score during infusion) was recorded in 7/12 in the ketamine, 4/12 in the lidocaine and 2/12 in the placebo group. Quantitative sensory testing (QST) of thermal sensitivity and sensory tests for mechanical stimuli could not separate responders from non‐responders and neither were the results from these assessments changed by the infusion of the drugs. Lidocaine and particularly ketamine were associated with frequent side‐effects, the most common being somnolence and dizziness.Conclusion: Ketamine showed a significant analgesic effect. The clinical usefulness is, however, limited by disturbing side‐effects.